Comparison of Prostate Fusion Biopsies With Software and Cognitive
NCT ID: NCT04291742
Last Updated: 2020-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
804 participants
INTERVENTIONAL
2020-01-16
2022-02-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer
NCT06517901
Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer
NCT05818631
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection
NCT03819751
Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy
NCT04271527
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MR
NCT03149861
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
0: cognitive
target prostate biopsies by cognitive fusion
cognitive vs software
cognitive vs software
1: software
target prostate biopsies by software
cognitive vs software
cognitive vs software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cognitive vs software
cognitive vs software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mpMRI carried out in our center.
* Presence of lesions with PIRADSv.2 ≥ 3.
* Acceptance to participate in the study.
Exclusion Criteria
* Treatment with 5-ARIs (5-alpha-reductase inhibitors).
* Previous diagnosis of PCa.
* TR\> T3.
40 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitari Vall d'Hebron Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Celma, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital Vall d'Hebron, Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Vall d'Hebron
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR(AG)161/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.